This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: The University of Texas System, Sysmex Corporation. Active years: 2002-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 5,638 
1 out of 1,055 
Years Active: 2002-2011
Title: Naoto T Ueno: Innovator in Cancer Chemotherapy
Introduction
Naoto T Ueno is a prominent inventor based in Houston, TX (US), known for his significant contributions to cancer treatment methodologies. With a total of 3 patents, Ueno has focused on enhancing the effectiveness of chemotherapy through innovative approaches.
Latest Patents
Ueno's latest patents include a method for determining the chemosensitivity of cancer cells to taxanes. This invention assesses the effect of taxanes on the expression level or activity of various cell cycle molecules in cancer cells. The method utilizes an automated analyzer system to evaluate parameters such as CDK1 and CDK2 kinase activity, MAD2 expression, and Cyclin B1, among others. Another notable patent involves the use of nucleic acid encoding an E1A gene product to sensitize HER-2/neu overexpressing cancer cells to chemotherapy. This method aims to inhibit the p185neu tyrosine kinase, which is associated with chemoresistance, thereby enhancing the efficacy of chemotherapeutic agents.
Career Highlights
Throughout his career, Ueno has worked with esteemed organizations, including the University of Texas System and Sysmex Corporation. His work has been pivotal in advancing cancer treatment strategies, particularly in the realm of chemotherapy.
Collaborations
Ueno has collaborated with notable individuals in the field, including Mien-Chie Hung and Hideki Ishihara. These partnerships have contributed to the development of innovative cancer therapies.
Conclusion
Naoto T Ueno's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His patents reflect a commitment to improving treatment outcomes for patients, showcasing the vital role of inventors in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile